Fortress Biotech Return on Tangible Equity 2010-2024 | FBIO

Current and historical return on tangible equity values for Fortress Biotech (FBIO) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Fortress Biotech Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-03-31 $-0.06B $-0.02B 221.05%
2023-12-31 $-0.07B $-0.02B 284.54%
2023-09-30 $-0.09B $-0.03B 647.27%
2023-06-30 $-0.11B $-0.04B -823.08%
2023-03-31 $-0.10B $-0.01B -198.08%
2022-12-31 $-0.10B $0.02B -100.80%
2022-09-30 $-0.10B $0.07B -67.72%
2022-06-30 $-0.09B $0.12B -53.10%
2022-03-31 $-0.07B $0.16B -36.05%
2021-12-31 $-0.07B $0.21B -30.10%
2021-09-30 $-0.04B $0.20B -18.44%
2021-06-30 $-0.03B $0.24B -16.75%
2021-03-31 $-0.04B $0.23B -25.04%
2020-12-31 $-0.05B $0.18B -35.05%
2020-09-30 $-0.06B $0.17B -54.90%
2020-06-30 $-0.05B $0.11B -68.39%
2020-03-31 $-0.05B $0.07B -73.36%
2019-12-31 $-0.04B $0.07B -59.04%
2019-09-30 $-0.05B $0.07B -89.29%
2019-06-30 $-0.05B $0.09B -103.35%
2019-03-31 $-0.06B $0.05B -136.96%
2018-12-31 $-0.09B $0.02B -162.68%
2018-09-30 $-0.07B $0.05B -90.03%
2018-06-30 $-0.08B $0.06B -92.49%
2018-03-31 $-0.08B $0.08B -75.57%
2017-12-31 $-0.07B $0.12B -63.92%
2017-09-30 $-0.07B $0.09B -85.88%
2017-06-30 $-0.06B $0.12B -77.38%
2017-03-31 $-0.05B $0.09B -87.45%
2016-12-31 $-0.05B $0.05B -96.00%
2016-09-30 $-0.05B $0.05B -75.10%
2016-06-30 $-0.05B $0.06B -82.13%
2016-03-31 $-0.05B $0.07B -73.85%
2015-12-31 $-0.05B $0.08B -76.80%
2015-09-30 $-0.04B $0.05B -67.23%
2015-06-30 $-0.03B $0.05B -42.69%
2015-03-31 $-0.03B $0.06B -38.38%
2014-12-31 $-0.02B $0.07B -29.27%
2014-09-30 $-0.03B $0.07B -36.36%
2014-06-30 $-0.03B $0.07B -37.97%
2014-03-31 $-0.04B $0.08B -49.15%
2013-12-31 $-0.04B $0.08B -62.04%
2013-09-30 $-0.04B $0.09B -79.57%
2013-06-30 $-0.04B $0.05B -110.24%
2013-03-31 $-0.03B $0.03B -107.14%
2012-12-31 $-0.03B $0.02B -114.29%
2012-09-30 $-0.03B $0.03B -109.47%
2012-06-30 $-0.02B $0.03B -104.55%
2012-03-31 $-0.03B $0.01B -200.00%
2011-12-31 $-0.04B $0.02B -419.51%
2011-06-30 $-0.04B -1076.92%
2011-03-31 $-0.03B -861.54%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.041B $0.085B
Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $180.065B 18.02
Vertex Pharmaceuticals (VRTX) United States $126.026B 32.43
Regeneron Pharmaceuticals (REGN) United States $119.620B 29.25
CSL (CSLLY) Australia $99.826B 0.00
Gilead Sciences (GILD) United States $91.321B 18.19
Bristol Myers Squibb (BMY) United States $87.469B 41.10
GSK (GSK) United Kingdom $82.568B 9.86
Moderna (MRNA) United States $47.543B 0.00
Biogen (BIIB) United States $33.244B 15.22
Alnylam Pharmaceuticals (ALNY) United States $30.361B 0.00
Argenex SE (ARGX) Netherlands $27.541B 0.00
BioNTech SE (BNTX) Germany $20.556B 172.94
Illumina (ILMN) United States $19.098B 136.24
Genmab (GMAB) Denmark $17.743B 20.80
BioMarin Pharmaceutical (BMRN) United States $16.075B 62.71
BeiGene (BGNE) Cayman Islands $14.897B 0.00
Incyte (INCY) United States $14.663B 22.67
Sarepta Therapeutics (SRPT) United States $13.886B 1224.17
Bio-Techne Corp (TECH) United States $12.337B 46.60
Insmed (INSM) United States $11.226B 0.00
Legend Biotech (LEGN) United States $10.026B 0.00
QIAGEN (QGEN) Netherlands $9.694B 20.71
Exact Sciences (EXAS) United States $9.110B 0.00
Vaxcyte (PCVX) United States $8.853B 0.00
Roivant Sciences (ROIV) United Kingdom $8.311B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.085B 26.44
Intra-Cellular Therapies (ITCI) United States $8.078B 0.00
Ascendis Pharma (ASND) Denmark $8.069B 0.00
Repligen (RGEN) United States $7.393B 96.58
Blueprint Medicines (BPMC) United States $7.161B 0.00
Halozyme Therapeutics (HALO) United States $6.968B 19.35
Exelixis (EXEL) United States $6.825B 35.17
Zealand Pharma (ZLDPF) Denmark $6.491B 0.00
Cytokinetics (CYTK) United States $5.955B 0.00
Krystal Biotech (KRYS) United States $5.920B 0.00
Viking Therapeutics (VKTX) United States $5.496B 0.00
Nuvalent (NUVL) United States $5.197B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.136B 0.00
Apellis Pharmaceuticals (APLS) United States $4.793B 0.00
Immunovant (IMVT) United States $4.382B 0.00
Avidity Biosciences (RNA) United States $4.316B 0.00
ImmunityBio (IBRX) United States $4.239B 0.00
Alkermes (ALKS) Ireland $4.165B 16.30
Guardant Health (GH) United States $3.983B 0.00
Axsome Therapeutics (AXSM) United States $3.977B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.649B 0.00
Arcellx (ACLX) United States $3.505B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.334B 0.00
Merus (MRUS) Netherlands $3.319B 0.00
Denali Therapeutics (DNLI) United States $3.281B 0.00
Twist Bioscience (TWST) United States $3.273B 0.00
Biohaven (BHVN) United States $3.204B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.176B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.175B 0.00
Amicus Therapeutics (FOLD) United States $3.140B 0.00
IDEAYA Biosciences (IDYA) United States $3.081B 0.00
ADMA Biologics Inc (ADMA) United States $3.081B 120.82
ACADIA Pharmaceuticals (ACAD) United States $3.032B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.969B 0.00
SpringWorks Therapeutics (SWTX) United States $2.882B 0.00
Apogee Therapeutics (APGE) United States $2.877B 0.00
Kymera Therapeutics (KYMR) United States $2.874B 0.00
MorphoSys AG (MOR) Germany $2.839B 0.00
Geron (GERN) United States $2.823B 0.00
Morphic Holding (MORF) United States $2.819B 0.00
Certara (CERT) United States $2.662B 61.30
Intellia Therapeutics (NTLA) United States $2.640B 0.00
Celldex Therapeutics (CLDX) United States $2.556B 0.00
CG Oncology (CGON) United States $2.546B 0.00
Vericel (VCEL) United States $2.514B 0.00
Iovance Biotherapeutics (IOVA) United States $2.502B 0.00
Myriad Genetics (MYGN) United States $2.452B 0.00
Fortrea Holdings (FTRE) United States $2.411B 29.64
Janux Therapeutics (JANX) United States $2.277B 0.00
Novavax (NVAX) United States $2.225B 0.00
Beam Therapeutics (BEAM) United States $2.217B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.142B 0.00
Arvinas (ARVN) United States $2.134B 0.00
Protagonist Therapeutics (PTGX) United States $2.107B 14.72
NovoCure (NVCR) Jersey $2.056B 0.00
Bavarian Nordic (BVNRY) Denmark $2.052B 8.93
Syndax Pharmaceuticals (SNDX) United States $2.013B 0.00
Edgewise Therapeutics (EWTX) United States $2.007B 0.00
NeoGenomics (NEO) United States $1.980B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.950B 0.00
Vera Therapeutics (VERA) United States $1.925B 0.00
Neumora Therapeutics (NMRA) United States $1.898B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.879B 14.32
Akero Therapeutics (AKRO) United States $1.873B 0.00
Zai Lab (ZLAB) China $1.867B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.846B 0.00
Ligand Pharmaceuticals (LGND) United States $1.819B 29.73
Mirum Pharmaceuticals (MIRM) United States $1.808B 0.00
Keros Therapeutics (KROS) United States $1.794B 0.00
Structure Therapeutics (GPCR) United States $1.787B 0.00
Galapagos (GLPG) Belgium $1.779B 0.00
Kura Oncology (KURA) United States $1.655B 0.00
MannKind (MNKD) United States $1.579B 193.33
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.519B 0.00
Belite Bio (BLTE) United States $1.435B 0.00
Sana Biotechnology (SANA) United States $1.413B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.408B 0.00
Arcus Biosciences (RCUS) United States $1.408B 0.00
Vir Biotechnology (VIR) United States $1.397B 0.00
Dynavax Technologies (DVAX) United States $1.397B 177.83
Day One Biopharmaceuticals (DAWN) United States $1.368B 0.00
ANI Pharmaceuticals (ANIP) United States $1.321B 16.40
Gyre Therapeutics (GYRE) United States $1.295B 0.00
Prothena (PRTA) Ireland $1.284B 0.00
Spyre Therapeutics (SYRE) United States $1.265B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.189B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.179B 0.00
Disc Medicine (IRON) United States $1.177B 0.00
MiMedx (MDXG) United States $1.101B 46.62
Nurix Therapeutics (NRIX) United States $1.070B 0.00
Cullinan Therapeutics (CGEM) United States $1.067B 0.00
Tyra Biosciences (TYRA) United States $1.056B 0.00
Tango Therapeutics (TNGX) United States $1.043B 0.00
Immatics (IMTX) Germany $1.040B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.036B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.000B 0.00
AbCellera Biologics (ABCL) Canada $0.991B 0.00
Humacyte (HUMA) United States $0.973B 0.00
Viridian Therapeutics (VRDN) United States $0.973B 0.00
Praxis Precision Medicines (PRAX) United States $0.943B 0.00
AnaptysBio (ANAB) United States $0.941B 0.00
Rapport Therapeutics (RAPP) $0.925B 0.00
Cytek Biosciences (CTKB) United States $0.878B 0.00
Liquidia Technologies (LQDA) United States $0.866B 0.00
Cogent Biosciences (COGT) United States $0.859B 0.00
89BIO (ETNB) United States $0.854B 0.00
Mesoblast (MESO) Australia $0.843B 0.00
Immunome (IMNM) United States $0.839B 0.00
Nuvation Bio (NUVB) United States $0.838B 0.00
Abivax SA (ABVX) France $0.836B 0.00
CureVac (CVAC) Germany $0.817B 0.00
Dianthus Therapeutics (DNTH) United States $0.812B 0.00
CARGO Therapeutics (CRGX) United States $0.808B 0.00
Olema Pharmaceuticals (OLMA) United States $0.807B 0.00
Travere Therapeutics (TVTX) United States $0.783B 0.00
Tectonic Therapeutic (TECX) United States $0.778B 0.00
Pliant Therapeutics (PLRX) United States $0.776B 0.00
Prime Medicine (PRME) United States $0.755B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.735B 0.00
WAVE Life Sciences (WVE) Singapore $0.724B 0.00
Zymeworks (ZYME) United States $0.716B 0.00
Allogene Therapeutics (ALLO) United States $0.715B 0.00
Scholar Rock Holding (SRRK) United States $0.714B 0.00
Arbutus Biopharma (ABUS) United States $0.713B 0.00
Stoke Therapeutics (STOK) United States $0.713B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.709B 0.00
IGM Biosciences (IGMS) United States $0.703B 0.00
Mineralys Therapeutics (MLYS) United States $0.690B 0.00
Oric Pharmaceuticals (ORIC) United States $0.689B 0.00
ACELYRIN, INC (SLRN) United States $0.679B 0.00
ArriVent BioPharma (AVBP) United States $0.658B 0.00
REGENXBIO (RGNX) United States $0.654B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.654B 0.00
Replimune (REPL) United States $0.653B 0.00
Applied Therapeutics (APLT) United States $0.648B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Adaptive Biotechnologies (ADPT) United States $0.641B 0.00
Celcuity (CELC) United States $0.638B 0.00
Emergent Biosolutions (EBS) United States $0.630B 0.00
Terns Pharmaceuticals (TERN) United States $0.623B 0.00
Astria Therapeutics (ATXS) United States $0.622B 0.00
Avid Bioservices (CDMO) United States $0.621B 0.00
GRAIL (GRAL) United States $0.615B 0.00
GH Research (GHRS) Ireland $0.614B 0.00
ITeos Therapeutics (ITOS) United States $0.614B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.603B 0.00
Pharming Group (PHAR) Netherlands $0.596B 0.00
Alumis (ALMS) United States $0.587B 0.00
PepGen (PEPG) United States $0.579B 0.00
Entrada Therapeutics (TRDA) United States $0.578B 27.17
Neurogene (NGNE) United States $0.576B 0.00
Alector (ALEC) United States $0.562B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.557B 0.00
PureTech Health (PRTC) United States $0.555B 0.00
Pharming Group (PHGUF) Netherlands $0.555B 0.00
Erasca (ERAS) United States $0.553B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.552B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.546B 0.00
Annexon (ANNX) United States $0.542B 0.00
Contineum Therapeutics (CTNM) United States $0.542B 0.00
Castle Biosciences (CSTL) United States $0.536B 0.00
MaxCyte (MXCT) United States $0.526B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.524B 0.00
Fulcrum Therapeutics (FULC) United States $0.520B 0.00
Third Harmonic Bio (THRD) United States $0.512B 0.00
Fate Therapeutics (FATE) United States $0.508B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.504B 0.00
Anavex Life Sciences (AVXL) United States $0.501B 0.00
Absci (ABSI) United States $0.495B 0.00
Northwest Biotherapeutics (NWBO) United States $0.484B 0.00
Oculis Holding AG (OCS) Switzerland $0.475B 0.00
Voyager Therapeutics (VYGR) United States $0.475B 0.00
C4 Therapeutics (CCCC) United States $0.472B 0.00
Ocugen (OCGN) United States $0.471B 0.00
Editas Medicine (EDIT) United States $0.470B 0.00
Aura Biosciences (AURA) United States $0.457B 0.00
Kyverna Therapeutics (KYTX) United States $0.453B 0.00
Alto Neuroscience (ANRO) United States $0.438B 0.00
Precigen (PGEN) United States $0.437B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.428B 0.00
Anika Therapeutics (ANIK) United States $0.419B 359.38
Revance Therapeutics (RVNC) United States $0.414B 0.00
UniQure (QURE) Netherlands $0.411B 0.00
EnGene Holdings (ENGN) United States $0.401B 0.00
ALX Oncology Holdings (ALXO) United States $0.399B 0.00
Urogen Pharma (URGN) United States $0.396B 0.00
TScan Therapeutics (TCRX) United States $0.389B 0.00
Nkarta (NKTX) United States $0.374B 0.00
Agenus (AGEN) United States $0.372B 0.00
Cabaletta Bio (CABA) United States $0.365B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.362B 0.00
AC Immune (ACIU) Switzerland $0.356B 0.00
Inozyme Pharma (INZY) United States $0.355B 0.00
Scilex Holding (SCLX) United States $0.353B 0.00
Nautilus Biotechnology (NAUT) United States $0.347B 0.00
Solid Biosciences (SLDB) United States $0.342B 0.00
Kamada (KMDA) Israel $0.335B 25.30
XOMA Royalty (XOMA) United States $0.334B 0.00
Sutro Biopharma (STRO) United States $0.332B 0.00
Cartesian Therapeutics (RNAC) United States $0.328B 0.00
Atea Pharmaceuticals (AVIR) United States $0.326B 0.00
Q32 Bio (QTTB) United States $0.325B 0.00
Poseida Therapeutics (PSTX) United States $0.324B 0.00
MeiraGTx Holdings (MGTX) United States $0.321B 0.00
Amarin (AMRN) Ireland $0.320B 0.00
Jasper Therapeutics (JSPR) United States $0.318B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.313B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.311B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.309B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.305B 0.00
Alimera Sciences (ALIM) United States $0.291B 0.00
Inovio Pharmaceuticals (INO) United States $0.287B 0.00
Tenaya Therapeutics (TNYA) United States $0.286B 0.00
CorMedix Inc (CRMD) United States $0.267B 0.00
Mersana Therapeutics (MRSN) United States $0.264B 0.00
Design Therapeutics (DSGN) United States $0.252B 0.00
23andMe Holding (ME) United States $0.251B 0.00
Gossamer Bio (GOSS) United States $0.247B 0.00
2seventy Bio (TSVT) United States $0.245B 0.00
Codexis (CDXS) United States $0.243B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.239B 0.00
Molecular Partners AG (MOLN) Switzerland $0.239B 0.00
Caribou Biosciences (CRBU) United States $0.238B 0.00
Prima BioMed (IMMP) Australia $0.238B 0.00
GENFIT S.A (GNFT) France $0.235B 0.00
Shattuck Labs (STTK) United States $0.225B 0.00
Seres Therapeutics (MCRB) United States $0.224B 0.00
Abeona Therapeutics (ABEO) United States $0.222B 0.00
ChromaDex (CDXC) United States $0.220B 0.00
Renovaro (RENB) United States $0.212B 0.00
Oncobiologics (OTLK) United States $0.209B 0.00
Greenwich LifeSciences (GLSI) United States $0.209B 0.00
Ventyx Biosciences (VTYX) United States $0.209B 0.00
Generation Bio (GBIO) United States $0.202B 0.00
Inhibrx Biosciences (INBX) $0.201B 0.00
XBiotech (XBIT) United States $0.200B 0.00
Trevi Therapeutics (TRVI) United States $0.200B 0.00
Coherus BioSciences (CHRS) United States $0.200B 0.00
Candel Therapeutics (CADL) United States $0.196B 0.00
FibroBiologics (FBLG) United States $0.193B 0.00
Biomea Fusion (BMEA) United States $0.191B 0.00
Rani Therapeutics Holdings (RANI) United States $0.187B 0.00
Rezolute (RZLT) United States $0.186B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.184B 0.00
G1 Therapeutics (GTHX) United States $0.184B 0.00
Adverum Biotechnologies (ADVM) United States $0.182B 0.00
Adherex Technologies (FENC) United States $0.182B 221.67
INmune Bio (INMB) United States $0.180B 0.00
Innate Pharma S.A (IPHA) France $0.178B 0.00
Skye Bioscience (SKYE) United States $0.177B 0.00
Puma Biotechnology (PBYI) United States $0.176B 11.06
Syros Pharmaceuticals (SYRS) United States $0.175B 0.00
ScPharmaceuticals (SCPH) United States $0.174B 0.00
Adocia (ADOCY) France $0.174B 0.00
Lifecore Biomedical (LFCR) United States $0.169B 0.00
BioStem Technologies (BSEM) $0.162B 0.00
Compugen (CGEN) Israel $0.161B 0.00
Kodiak Sciences (KOD) United States $0.158B 0.00
Elevation Oncology (ELEV) United States $0.158B 0.00
Vigil Neuroscience (VIGL) United States $0.157B 0.00
Repare Therapeutics (RPTX) Canada $0.156B 0.00
Zura Bio (ZURA) United States $0.153B 0.00
Invivyd (IVVD) United States $0.150B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.149B 0.00
DiaMedica Therapeutics (DMAC) United States $0.147B 0.00
PDS Biotechnology (PDSB) United States $0.147B 0.00
Compass Therapeutics (CMPX) United States $0.142B 0.00
Annovis Bio (ANVS) United States $0.139B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.136B 0.00
Bluebird Bio (BLUE) United States $0.133B 0.00
Immunic (IMUX) United States $0.132B 0.00
Inventiva S.A (IVA) France $0.131B 0.00
Athira Pharma (ATHA) United States $0.130B 0.00
Adlai Nortye (ANL) Cayman Islands $0.130B 0.00
Akoya Biosciences (AKYA) United States $0.128B 0.00
Rapt Therapeutics (RAPT) United States $0.127B 0.00
Werewolf Therapeutics (HOWL) United States $0.125B 0.00
X4 Pharmaceuticals (XFOR) United States $0.125B 0.00
Nuvectis Pharma (NVCT) United States $0.124B 0.00
I-Mab (IMAB) China $0.123B 0.00
Semper Paratus Acquisition (TVGN) United States $0.121B 0.00
Opthea (OPT) Australia $0.121B 0.00
Seer (SEER) United States $0.120B 0.00
Cellectis S.A (CLLS) France $0.117B 0.00
ATyr Pharma (ATYR) United States $0.117B 0.00
Adagene (ADAG) China $0.115B 0.00
TELA Bio (TELA) United States $0.114B 0.00
CervoMed (CRVO) United States $0.114B 0.00
Cardiff Oncology (CRDF) United States $0.114B 0.00
CytomX Therapeutics (CTMX) United States $0.112B 7.20
Omega Therapeutics (OMGA) United States $0.109B 0.00
Adicet Bio (ACET) United States $0.108B 0.00
Coya Therapeutics (COYA) United States $0.105B 0.00
VistaGen Therapeutics (VTGN) United States $0.104B 0.00
Sagimet Biosciences (SGMT) United States $0.103B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Elutia (ELUT) United States $0.098B 0.00
BioHarvest Sciences (CNVCF) Canada $0.097B 0.00
Checkpoint Therapeutics (CKPT) United States $0.095B 0.00
InflaRx (IFRX) Germany $0.094B 0.00
Boundless Bio (BOLD) United States $0.093B 0.00
Eton Pharmaceuticals (ETON) United States $0.092B 89.75
HilleVax (HLVX) United States $0.092B 0.00
Benitec Biopharma (BNTC) United States $0.091B 0.00
Sangamo Therapeutics (SGMO) United States $0.090B 0.00
Clearside Biomedical (CLSD) United States $0.090B 0.00
BeyondSpring (BYSI) United States $0.090B 0.00
AN2 Therapeutics (ANTX) United States $0.088B 0.00
BioAtla (BCAB) United States $0.087B 0.00
IO Biotech (IOBT) Denmark $0.087B 0.00
Verastem (VSTM) United States $0.087B 0.00
Instil Bio (TIL) United States $0.085B 0.00
Chimerix (CMRX) United States $0.085B 0.00
Kronos Bio (KRON) United States $0.084B 0.00
Affimed (AFMD) Germany $0.084B 0.00
Genelux (GNLX) United States $0.084B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.084B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.083B 0.00
Ikena Oncology (IKNA) United States $0.082B 0.00
DBV Technologies S.A (DBVT) France $0.081B 0.00
Oncolytics Biotech (ONCY) Canada $0.081B 0.00
Spero Therapeutics (SPRO) United States $0.080B 2.90
LENZ Therapeutics (LENZ) United States $0.080B 0.00
Alpha Teknova (TKNO) United States $0.078B 0.00
Cognition Therapeutics (CGTX) United States $0.077B 0.00
Gritstone Bio (GRTS) United States $0.076B 0.00
Allakos (ALLK) United States $0.073B 0.00
Ovid Therapeutics (OVID) United States $0.072B 0.00
Precision BioSciences (DTIL) United States $0.072B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.071B 0.00
Earth Science Tech (ETST) United States $0.071B 0.00
Theratechnologies (THTX) Canada $0.071B 0.00
Connect Biopharma Holdings (CNTB) United States $0.069B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.068B 0.00
Vor Biopharma (VOR) $0.068B 0.00
MediciNova (MNOV) United States $0.068B 0.00
Entera Bio (ENTX) Israel $0.068B 0.00
VTv Therapeutics (VTVT) United States $0.067B 0.00
Intensity Therapeutics (INTS) United States $0.066B 0.00
Eyenovia (EYEN) United States $0.066B 0.00
Genenta Science S.p.A (GNTA) Italy $0.066B 0.00
Aileron Therapeutics (ALRN) United States $0.065B 0.00
HOOKIPA Pharma (HOOK) United States $0.064B 0.00
Galena Biopharma (SLS) United States $0.064B 0.00
Celularity (CELU) United States $0.063B 0.00
Enzo Biochem (ENZ) United States $0.060B 0.00
Cidara Therapeutics (CDTX) United States $0.059B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.059B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.059B 0.00
Turnstone Biologics (TSBX) United States $0.058B 0.00
Atara Biotherapeutics (ATRA) United States $0.058B 0.00
Passage Bio (PASG) United States $0.058B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.058B 0.00
Rallybio (RLYB) United States $0.058B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Leap Therapeutics (LPTX) United States $0.056B 0.00
Aerovate Therapeutics (AVTE) United States $0.054B 0.00
Ocuphire Pharma (OCUP) United States $0.053B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.053B 0.00
Lantern Pharma (LTRN) United States $0.052B 0.00
ARCA Biopharma (ABIO) United States $0.051B 0.00
CalciMedica (CALC) United States $0.049B 0.00
Kezar Life Sciences (KZR) United States $0.049B 0.00
NextCure (NXTC) United States $0.049B 0.00
Elicio Therapeutics (ELTX) United States $0.049B 0.00
BioXcel Therapeutics (BTAI) United States $0.048B 0.00
Estrella Immunopharma (ESLA) United States $0.047B 0.00
OKYO Pharma (OKYO) $0.046B 0.00
Lexaria Bioscience (LEXX) Canada $0.046B 0.00
LakeShore Biopharma (LSB) China $0.045B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
Cue Biopharma (CUE) United States $0.044B 0.00
Ocean Biomedical (OCEA) United States $0.043B 0.00
Dyadic (DYAI) United States $0.042B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.042B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.042B 0.00
Promis Neurosciences (PMN) Canada $0.041B 0.00
Aligos Therapeutics (ALGS) United States $0.040B 0.00
Curis (CRIS) United States $0.039B 0.00
Aadi Bioscience (AADI) United States $0.039B 0.00
IN8bio (INAB) United States $0.038B 0.00
MiNK Therapeutics (INKT) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Cyclo Therapeutics (CYTH) United States $0.036B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.035B 0.00
Immuneering (IMRX) United States $0.035B 0.00
Quince Therapeutics (QNCX) United States $0.033B 0.00
Equillium (EQ) United States $0.033B 0.00
Pluri (PLUR) Israel $0.031B 0.00
Clene (CLNN) United States $0.031B 0.00
RenovoRx (RNXT) United States $0.030B 0.00
Lisata Therapeutics (LSTA) United States $0.030B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.030B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Carmell (CTCX) United States $0.029B 0.00
Bolt Biotherapeutics (BOLT) United States $0.028B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.028B 0.00
BioAffinity Technologies (BIAF) United States $0.027B 0.00
Biora Therapeutics (BIOR) United States $0.027B 0.00
SAB Biotherapeutics (SABS) United States $0.027B 0.00
Beyond Air (XAIR) United States $0.026B 0.00
Femasys (FEMY) United States $0.026B 0.00
Evogene (EVGN) Israel $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Longeveron (LGVN) United States $0.025B 0.00
HCW Biologics (HCWB) United States $0.025B 0.00
Orgenesis (ORGS) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.025B 0.00
NKGen Biotech (NKGN) United States $0.024B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.023B 0.00
Spruce Biosciences (SPRB) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.023B 0.00
Aprea Therapeutics (APRE) United States $0.022B 0.00
KALA BIO (KALA) United States $0.021B 0.00
Forte Biosciences (FBRX) United States $0.021B 0.00
VBI Vaccines (VBIV) United States $0.021B 0.00
Apollomics (APLM) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Synlogic (SYBX) United States $0.019B 0.00
Cara Therapeutics (CARA) United States $0.019B 0.00
Sensei Biotherapeutics (SNSE) United States $0.018B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
BRIACELL THERAP (BCTX) Canada $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
Evaxion Biotech (EVAX) Denmark $0.016B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Galecto (GLTO) Denmark $0.015B 0.00
Kintara Therapeutics (KTRA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.015B 0.00
Imunon (IMNN) United States $0.014B 0.00
Senti Biosciences (SNTI) United States $0.013B 0.00
Chemomab Therapeutics (CMMB) Israel $0.013B 0.00
Monopar Therapeutics (MNPR) United States $0.012B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.012B 0.00
Lumos Pharma (LUMO) United States $0.012B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.012B 0.00
Aptose Biosciences (APTO) Canada $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.011B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.011B 0.00
Novogen (KZIA) Australia $0.011B 0.00
AEterna Zentaris (AEZS) Canada $0.011B 0.00
Vaccinex (VCNX) United States $0.011B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
ABVC BioPharma (ABVC) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.010B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
Purple Biotech (PPBT) Israel $0.010B 0.00
Kineta (KA) United States $0.009B 0.00
Organovo Holdings (ONVO) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
ANEW Medical (WENA) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
GeoVax Labs (GOVX) United States $0.007B 0.00
Bionomics (BNOX) Australia $0.007B 0.00
Soligenix (SNGX) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Telesis Bio (TBIO) United States $0.007B 0.00
Notable Labs (NTBL) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Virios Therapeutics (VIRI) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Trevena (TRVN) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Allarity Therapeutics (ALLR) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Psyence Biomedical (PBM) United States $0.003B 0.00
Portage Biotech (PRTG) $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
Cingulate (CING) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00